Cardinal Health Return on Tangible Equity 2010-2023 | CAH

Current and historical return on tangible equity values for Cardinal Health (CAH) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Cardinal Health Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2023-12-31 $0.64B $-8.82B -7.21%
2023-09-30 $0.16B $-8.92B -1.76%
2023-06-30 $0.26B $-8.93B -2.92%
2023-03-31 $0.46B $-8.79B -5.28%
2022-12-31 $-1.27B $-8.83B 14.54%
2022-09-30 $-1.09B $-9.15B 12.95%
2022-06-30 $-0.93B $-8.34B 11.22%
2022-03-31 $-0.96B $-8.72B 11.50%
2021-12-31 $0.56B $-7.60B -6.75%
2021-09-30 $1.14B $-8.61B -13.19%
2021-06-30 $0.61B $-8.30B -6.87%
2021-03-31 $1.15B $-8.39B -12.53%
2020-12-31 $1.38B $-9.13B -14.34%
2020-09-30 $0.97B $-9.76B -9.75%
2020-06-30 $-3.70B $-9.48B 36.12%
2020-03-31 $-4.16B $-10.17B 45.04%
2019-12-31 $-4.21B $-10.52B 52.03%
2019-09-30 $-4.15B $-10.76B 59.76%
2019-06-30 $1.36B $-5.48B -23.48%
2019-03-31 $0.00B $-5.63B -0.03%
2018-12-31 $-0.04B $-5.93B 0.62%
2018-09-30 $0.73B $-6.18B -11.35%
2018-06-30 $0.26B $-6.17B -3.67%
2018-03-31 $1.70B $-6.76B -28.14%
2017-12-31 $1.82B $-6.75B -36.50%
2017-09-30 $1.09B $-8.23B -27.07%
2017-06-30 $1.29B $-2.38B -47.56%
2017-03-31 $1.35B $-2.62B -47.61%
2016-12-31 $1.35B $-2.94B -48.66%
2016-09-30 $1.35B $-2.90B -51.27%
2016-06-30 $1.43B $-2.86B -65.63%
2016-03-31 $1.39B $-2.42B -99.21%
2015-12-31 $1.37B $-2.39B -192.28%
2015-09-30 $1.33B $-1.04B -2229.29%
2015-06-30 $1.22B $0.24B 429.71%
2015-03-31 $1.15B $0.34B 324.16%
2014-12-31 $1.10B $0.22B 217.86%
2014-09-30 $1.09B $0.33B 154.16%
2014-06-30 $1.17B $0.53B 144.40%
2014-03-31 $0.35B $0.94B 44.77%
2013-12-31 $0.38B $1.03B 58.49%
2013-09-30 $0.40B $0.73B 43.95%
2013-06-30 $0.33B $0.40B 28.00%
2013-03-31 $1.16B $0.42B 74.30%
2012-12-31 $1.14B $2.11B 59.62%
2012-09-30 $1.10B $1.84B 60.91%
2012-06-30 $1.07B $1.85B 62.25%
2012-03-31 $1.04B $1.87B 62.66%
2011-12-31 $0.95B $1.68B 61.87%
2011-09-30 $0.90B $1.47B 64.53%
2011-06-30 $0.96B $1.59B 59.36%
2011-03-31 $0.98B $1.39B 49.60%
2010-12-31 $0.96B $1.14B 39.78%
2010-09-30 $0.98B $2.34B 34.23%
2010-06-30 $0.64B $3.02B 21.90%
2010-03-31 $0.69B $3.10B 18.26%
2009-12-31 $0.78B $2.93B 21.82%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $25.909B $205.012B
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $69.110B 18.50
Becton Dickinson (BDX) United States $67.086B 19.48
West Pharmaceutical Services (WST) United States $27.625B 46.70
Align Technology (ALGN) United States $22.586B 45.54
Cooper (COO) United States $17.860B 27.03
Labcorp (LH) United States $16.823B 14.37
Henry Schein (HSIC) United States $9.019B 15.60
DENTSPLY SIRONA (XRAY) United States $6.296B 16.59
Merit Medical Systems (MMSI) United States $4.152B 23.76
Patterson (PDCO) United States $2.305B 11.04
STAAR Surgical (STAA) United States $2.264B 71.29
CONMED (CNMD) United States $2.240B 21.09
Atrion (ATRI) United States $0.702B 36.15
Lifevantage (LFVN) United States $0.085B 13.75
Pro-Dex (PDEX) United States $0.064B 24.35
Biolase (BIOL) United States $0.005B 0.00